SARS-CoV-2 and the cardiovascular system

dc.creatorHafiane, Anouar
dc.date.accessioned2020-10-05T16:58:46Z
dc.date.available2020-10-05T16:58:46Z
dc.date.issued2020-11
dc.description.abstractThe coronavirus disease COVID-19 is a public health emergency caused by a novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection uses the angiotensin-converting enzyme 2 (ACE2) receptor, and typically spreads through the respiratory tract. Invading viruses can elicit an exaggerated host immune response, frequently leading to a cytokine storm that may be fueling some COVID-19 death. This response contributes to multi-organ dysfunction. Accumulating data points to an increased cardiovascular disease morbidity, and mortality in COVID-19 patients. This brief review explores potential available evidence regarding the association between COVID-19, and cardiovascular complications.pt_BR
dc.identifier.citationHAFIANE, A. SARS-CoV-2 and the cardiovascular system. Clinica Chimica Acta, [S.l.], v. 510, p. 311-316, Nov. 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/43318
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0009898120303430pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceClinica Chimica Actapt_BR
dc.subjectCOVID-19pt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectMyocardial injurypt_BR
dc.subjectAngiotensin-converting enzyme 2 (ACE2)pt_BR
dc.subjectSevere acute respiratory syndromept_BR
dc.subjectTroponinpt_BR
dc.titleSARS-CoV-2 and the cardiovascular systempt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição: